0001299933-15-000907.txt : 20150605 0001299933-15-000907.hdr.sgml : 20150605 20150605093858 ACCESSION NUMBER: 0001299933-15-000907 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20150605 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150605 DATE AS OF CHANGE: 20150605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE, INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36385 FILM NUMBER: 15914633 BUSINESS ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: BIOLASE TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 8-K 1 htm_51960.htm LIVE FILING Biolase, Inc. (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   June 5, 2015

Biolase, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 000-19627 87-0442441
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
4 Cromwell, Irvine, California   92618
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   949-361-1200

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure.

On June 5, 2015, the Company issued a press release regarding the price of its Common Stock, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.





Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. See "Exhibit Index" attached to this Current Report on Form 8-K, which is incorporated by reference.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Biolase, Inc.
          
June 5, 2015   By:   /s/ Jeffrey M. Nugent
       
        Name: Jeffrey M. Nugent
        Title: President and Chief Executive Officer

Exhibit Index


     
Exhibit No.   Description
 
99.1
  Press Release of Biolase, Inc., dated June 5, 2015.
EX-99.1 2 exhibit1.htm EX-99.1 EX-99.1

BIOLASE COMMENTS ON RECENT DECLINE IN STOCK PRICE

IRVINE, CA (June 5, 2015) — BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that it is not aware of any fundamental reason for the recent decline in the price of BIOLASE common stock.

President and Chief Executive Officer Jeffrey M. Nugent said, “We believe we are continuing to make excellent progress in the transformation of BIOLASE. In the first quarter of this year, we continued to revitalize our core dental laser franchise on multiple fronts: worldwide unit sales of our WaterLase® product line increased year over year by 9 percent, the first increase in two years; domestic unit sales and revenue of our EPIC™ diode lasers grew year over year 44 percent and 38 percent, respectively; customer satisfaction improved significantly; and we introduced two new dental laser systems and our breakthrough ‘Practice Growth. Guaranteed™’ initiative.

“We are encouraged by the Company’s progress to date, and I believe in 2015, BIOLASE will achieve its twin goals of beginning to drive long term improvements in top and bottom line performance,” Nugent added. “I look forward to welcoming Harold Flynn when he becomes our new President and CEO on July 13 of this year, and I am committed to helping him during the transition.”

About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers. BIOLASE’s products are focused on technologies that advance the practice of dentistry to both the dentist and their patients. The Company’s proprietary laser products incorporate approximately 200 patented and 150 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 28,300 laser systems. Laser products under development address the Company’s core dental market and other adjacent medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Google+ at www.google.com/+BIOLASEIrvine, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements contained in this press release that refer to BIOLASE’s estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements in this press release concerning prospects related to BIOLASE’s strategic initiatives and anticipated financial performance. Forward-looking statements can also be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE’s current expectations regarding existing trends, our strategic initiatives, the closing of the private placement and expected use of proceeds and speak only as of the date of this release. Actual results may differ materially from BIOLASE’s current expectations depending upon a number of factors affecting BIOLASE’s business. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that may be detailed, from time-to-time, in BIOLASE’s reports filed with the SEC. BIOLASE does not undertake any responsibility to revise or update any forward-looking statements contained herein.

For further information, please contact:

     
BIOLASE, Inc.   Allen & Caron
David Dreyer
Chief Financial Officer
  Rene Caron (Investors)
949-474-4300

ddreyer@biolase.com rene@allencaron.com

     
888-424-6527  
Len Hall (Media)
949-474-4300
len@allencaron.com
   
 

GRAPHIC 3 e41523-1515693357311193e6_1.jpg GRAPHIC begin 644 e41523-1515693357311193e6_1.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_ MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`!"`)L#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^CSX$_MA_ M$CX7Q6NA^((;KQ]\/]-@M87L[MG.N>&M+CF^Q1MHVME6S:0RWEG;PZ9K?VFR M"6^GZ/I-SH43PP02:IH5X%LO$.B2310R&' M4]*D7VC:CX7N;B\U+PQX*\+?!_XD>)FFUZ/Q-H\%_9:_KW@?X7>"=3\++93W ME[X7UCQ'?R0ZKINFW#>'^[O_`(5>(M=^.NM0^%?&LOA+QK%\1->\':??>&/! M_B+P!H_AQ='T+1;K3[F!'U0ZCX* M[6^LO\;OHX>,GC_X<\'\(JB\?XR<)9G/@_+L+P=GN+R/+>)LL?$^`S#%X>AP M=Q1B^),3CL;1P-'!86A@^'\VRO$4:E&2IX6?#E"$I'^='@_XE>*W!N19!34< M5XA=83%8BC1X>SBOG%;&5X8:G0PU/#Y3CL#7HR MI2Y*,\FIQ;?[6T5^6OP0_;]E`M-!^.%C@,-J>.]#M-\D9/V?:OB'P]I]NB.% M!O'FU3P[`A.VSM8O#3%[B_'Z::'KVB>)M+M-<\.ZOINNZ/?+(UEJFD7MMJ.G MW2PS26\WD7=I)+!*8;B&6WF"2$PW$4L$@66-T7_2GP<^D!X6>.V4SS+P]XDH M8[&82E"IFW#F.]G@N)LDYW&'_"EE+JU)_5_:R5&GF6!JXW*,154J>$S"O*,D MO[1\//%?@?Q0P$L9PGG%/$XBA3C/'Y/BN7"YUEO,U'_;,`YSE[+GDJ<<9AIX MG`5:EX4,75E&26M1117[0?HP4444`%%%%`!1110`4444`%%%%`!1110`4444 M`?SU_M5_\$W/VN/#FKZIXI_97\9>$OBCX6GDTZ6W^'OCG3O"'A_XDZ8]O=VO MV6UL/$^HVNE>"/%-CIEY-J6N07VKW_@B_P!*M#%86EEX@U9)-2U#XK\-_$?1 M/V,_V?\`XE_%K_@HW^S5\8R=/^-/A#X*_"_P]X2\%:7X)&H:UK_A?XC>,=:O M;._U?4_"WAO7O!WG_#5#<^*/"]YXHB:^ET*XL+6_L[P7T']=%?SA?\'0'_)@ MOPB_[._\`_\`JF/C_7XYX'_0#^C3Q/\`2`\/J>8\"9=4X:S?/*N$SG@ZK@\! MBLAQM/%Y?C:,)4(XG"U,9@YX>I4C7HJ.*K4J3HTJ>&I8:$=?XSXX^C+X:<(U M*+W3%E9;*[U#]KW4M,O MKB#/R276GVWP,U>WM)6'+P1:G>HAX%Q(/F/WY^P3_P`%SOV&]0\?Z+X/\<_# MCXI_LD:MXYUZ#05\0ZC\4+3XI?`BW6<;M-O?B)XBU+3_``9?^%A=W\5KHP\2 M'X>7FF>&X-2FU'7O%WAGPS'K6L6GMO\`P0K_`&*_V0OBC_P3O^&7Q+^*/[,7 MP(^*'C[Q3XI^*$.N>+/B5\+/!GQ`UF[@T'XA^)-%TF"*[\7Z/K+6$%EIEI;6 MB0Z<+2)UA229))LR'\&_^"_'[-7[+W[,'[7G@[PA^S1X\5ZOXR\8"PU.W@U#5-3M?#$NOZ#!8B+P5HD>CZ1HND:5H^J MV.BVEOXBBN+O_2O@GZ(?[//-?&'/_##@+Z,&!\-^/>%L5Q#@\K\1N&/:4\7@ M<9D$J^"QV-H5:F98N.!I5Y*4:$JV#K4L5[6&%K1P_P!85*7R]+A7._#_`(>X M<\5L)A/#ODJO+L71P>#X/R+*,RI0S."G1I4U3 M2=`L9==CT74-=,GB3Q%J*WT^BZ2;/3IH_MFE^'O$EY]I>)/[,\IGFC]0_8-_ M:UC_`&U_V2/A?^U1<^!HOA3!\1U\?23>#9/%J^,8?#T7@7XD^,_A])+)XKD\ M.^$%OX[]/"!UIW?P_IJV"WYL6-R+,WUQ_+-_P5=G\47'_!$O_@D]-XO$']KO MI/PJ-N]NT;I+X<'P%U1?!L\CQ/(&NKCP>-"GO6=O.:\DG-PJ3^8BU_'O[0WB MOX(_\&S?[+?@[P3K=MH^L?M$?$_XL?![Q%)#JFH:;XD'PSE^.W[1GC'QS_8/ M]F:E83RV>M/X6T'P#XPBO8=2T6^\'>.=;T'4;(R:Y9S1=]#Z.^09KX6\"T\J MC%\=\2>/6/\`#G&\5/$XZKA%D.7+C"CB:]#*%C?[/]C"GD=',[QIO&U'0]A# M'1I5IJ7[=+Q5S3!<8\35,!/@+\-?%?[3VL>&==?1M2 M\76/BC2?AS\(M4%M&$U&Y\&^-WTKQSX@\5Q6.HB?3H]0@\!6/AC6UMSJ_AGQ M-K>@W6G:I>_-7@S_`(.J?!M]XETNU^(7[%?B;POX.FG"ZUKO@SXZZ5X\\2Z? M;8.9=+\)ZW\*_AQI>L3YP!;W?C/0X^I-UQ@^/?\`!#?_`((U?`K]HGX(R_M= M?M:^&;GXB^'_`!KK>MZ#\%/AB=?U+1/"Z:/X+\1C1]>^)7B2\\'>)-.U_6=5 MO/&.@^(O!.D>#-;;3-`T_1]$UW6=;TCQBOB_PO<^$?VV_:,_X(:_\$[OCQX$ MUGP]H'P.\/\`P,\;2:.;'PE\2OA"E]X:U#POJ<4EI-:ZC>>$[74H/!?C&"8V M26.LVWB?1KR_O-)O=572=9T#7KJU\0V'O<0T?H7^'O$F(\.:T^3#XVI'!8'B'*\/B)95B_;PQ]/#Y'RT:^'KTL-ALTY84 MY^;E=3Z07%&4TN*\OS[AW*,)F-%9CEG#U7`X3VE;!3YJN'A[;$91C)TXXRBJ M3PLJ^9WJ4JT*E:MA/B7VQ^R+^V;^S]^V_P#"VR^+'[/_`(RC\0Z5LLH/$_AG M4HDTOQQ\/=>N[5;F3POXZ\.&>XDTG5[5A<01W=G,?B;XL\>:+X/@T/Q98 M?$27X=:QKGAGPAH_A_QU)XK\/07]M=:AICZIXE\&:EJ-FMNEU8:3-/(MM_/; M_P`$:?B?X_\`V&_^"L0_9J\8^*-.L=#\9?$'XB_LI_&73-.OM6U/PIJ_CSPG MJ7B31?`VHZ%$9=(MKK5K?XN:!IGA_P`-^)M7T:6]LO"OC#Q986UEIS^)+XQ^ M;>&?^5@>Y_[2M>+/_6H-9KW\O^BYP'DO''B=@,RAB^*.%<)X4SX_\/\`%5

OA:N#KXG#/ZQ*D>7B?&7B;,.' MN#\1A9T,GSNMQI_JSQ10IX2A64O8/"3?U>EC8XIX:GBJ.(Y*C_BTZ]/$0HU8 MJG&1_HK445GZMJNFZ%I>I:WK6H6>DZ/H]A>:IJNJ:CGZ;INGV\EW?7]] M>3O'!:6=G:Q2W%UB26K;T2/P@_P""A'_!>[X0?L,_ M&KQE^SKI?P*\?_&#XL^`$\+2>)Q<>)="^'7@"!?%WA+0?&VF0:?XJ^Q>.-?O M[R/0?$>FRWB'P/;6<-S*UM%?7#1RLGW[_P`$XOVZ_#/_``4._9IT[X_:%X1_ MX5[JT'C'Q9X"\;_#[_A(IO%X\'>)_#ES;7MI8+XIE\,^$$UP:OX+UOPCXL\^ MWT&SAL3XB.C,]S<:9/(KVXMC\1_%L&I:%\#_`(>IXYF71;:"#PE\1/B)X+O[*^U:/3-) MO_#_`(#N[&ZTR#2I)[*#]2/^#6KX]7EIX^_:<_9@O[G6[JP\0>$?#GQX\*6@ MEA;PYH5WX0UBT^'WQ!N#"Q\]-:\6P^-_AE&)8@T,MCX**3&-XH?-_P!!?%CZ M.OAQPMX-YY_J[@L1+Q5\.,IX#SWCO&2S;&UW6AQ%"KA,RPD,NGCJ^54,+&I3 MQ6;TIX7"QG"A@84:&98N2Q5"?\N<$>*O%F=7<.898& MA35.66.%;"5?K<<)2QM6KRSH8*HJU:474Q$JE7"8=>QG'^HC]K_]L7X'?L._ M!O4OC;\>M>O]*\-07R:%H.C:%IQUCQ7XV\6W6G:EJ>F>#_">EM/96ESKFIVN MDZA+#-JVI:-H-C#:SWNMZWI.FP3WL7\W>N?\'5VBV^LZG!X:_8*+'2+V:/:T^GVGB/6X+=RT<>I72@2- MP'_!U1=:^_C?]BZRN+8KX6M_"WQQNM'NS"H$VOWFK?"Z+Q+;K/C?(;73K'PG M(T).V$7:NO,[5^C7_!(S]CW_`()4_%S]C;X2>*_!7P<_9^^.OQ*NO`'@F;]H M&Z^(N@Z+\5/''A;XP3Z*MIXTTC6]`^(%MJ]_\/-//BC2O$$?A33].T?P_H7B M'PW967B70CKFF:E#K^I?)\(>'_@MP+X%<+^+?B;P7Q1XBXOC/,\PP=+#9/F> M897E'#M/!YGF&7X>&+Q>69GE;IU,5'+JD_:8NIBI5<75>"H8:DL/4Q$_;SSB MGQ!XD\2O&'P0_X9H'P9_X13X0Z[\5 M?^$G_P"%S'XB_;_[%\9>`O"/]A?V+_PJGP+]E^U?\)O_`&A_:G]K7/D?V7]D M_LZ7[;]IM/SCF_X.L##-+#_PP:&\J62/=_PU$5W;&*[L?\,ZG&<9QDXZ9-?T M]_"O]E/]F#X%^(+SQ9\%/V=?@=\(O%.HZ/<>'=0\2?#/X5>!_`VNWV@7=[I^ MI76B7FK>&=#TR_N=)N-1TG2K^;3IIWM);S3;&Y>$S6L#I_GY?\$4OA3\-?C5 M_P`%)OA)\//BYX$\+?$CP)K&D?&"XU7PCXST6Q\0>'M1GTKX9>+]3TV6\TK4 M89[2X>QU&UMKVU:2)C#& MLZRSANMQ7Q(\PHU:.7\78S/G2Q^'X@I3KSS3^R,&J,,;B:U+#2I)450C4K<_ MF<KE'_`$93^S/_`.&?\%__`"IK[QL+&TACM[2SLK2)(+6UM;>)5B@M[>"-(888U5(XT M5$4*`*_G+Q6XE\%,]PF3TO"CPXS?@C%T,3BJF(,TSCZ]AY4J,<)AZ%' M'9SFE*C[.JJ]6K4C"C4?[N*E*+E&/ZSP5E'B'EN(QU3C;BO`<0T*E&C#`4,# MEN#P/U>LIR=>K5GA\NP,Y\T.2$(N4XZSDXQ?*6J_G"_X.@/^3!?A%_V=_P"` M?_5,?'^OZ/:_G"_X.@/^3!?A%_V=_P"`?_5,?'^MOHU_\GV\,?\`LIL/_P"H M^()\6_\`DVW&'_8HJ?\`IVD?SF?LB?\`!)?_`(*#_M6?`KPQ\:_@#KWABQ^& M'B34/$MAHMMJ7Q;U'PG>)=^'M?U#0]9,FB6]I)%;A]5L;MDD5S]I0B=L%R!X M'X^_9M^-O_!-;]I#X5:O^V_^RKH_Q!T&YU9O&4'@+QMXNFOOA]\8?#^CZW]D MUV/3OB!\,_$=_9#7+.5K?4)='U]M9;1WU7PU??$CX:Z_X7\01>'O$']%O_!' M;_@K%^P!^RM^P3\+?@M\>?CX?`OQ,\.>(OB;?ZSX:'PK^-7BC[':^(?B%XBU MS1Y/[9\&?#CQ%H%Q]KTN^M;K9:ZK.]OYOD72PW"2PI^9'_!>O_@HU^SO^WCX MZ^`/AS]G"^\1^*?"OP)L?B;)J7Q$U3P_J?A71/%VH?%*'X87*VOAG0_$EKIG MB^&W\,CP--9:G?>(M"T)[W4KJ9-,LKG2[2UU?4_](^%^//'#/_'#B?@#B+PZ MKX/PIQ&9\9Y:^+X<-<2\.5UDF"I9I3R;&X+BJ&-P>&Q=?,ZT'65^'>4<497Q53K<:PPN1XO\`L*6:91FM.685ZN$E MC\/B,F^K5J]"GA*;Q%64,4_8Q=%8;$JJZD:VL5CJ.A7%EX#\9Z)KWA35K.VEN+*VUGP=XCTO5_ M"NLQ:;=WVE+JFCW?]DZCJ.F_9;V?\@_VQ++4I/\`@D9_P1KU&*VNGTBUU#_@ MH597UXD4IL8-1O\`]H_2Y]*MKB<*8([N[MM-UB6SAD=99X;*_>%72WG*?4_[ M<'@'Q;\-?^""?_!+WPUXVTB30];O/BMX_P#&]O8RSVMQ(_AGXG:C\9_B5X(U M)GM)YXHSK7@KQ;X?UG['(Z7M@+\66HV]KJ%O=6L/U*O[*_CC]J3_`(-G?V>( MOAO:W^L^,_@5X]^*_P`>['PEI6G6M]J?C/1?"_QY_:.\*>,M&L9+K5--:UN= M(\'^-]<\=V\-A!K>L>(+GP=!X2T30K[6/$-B]O\`(\&X[A[PTX-\*H4L;2EP MSD?TJ>.>%<#F6,Q<)T?[-Q^`\5N$LLQ^)QU.#HR@J>.PV)JXQJGA6DZ]6K0P M_/6I^[GN&S7B_/>-Y3P\EF^8^#?#.=XG"4<.U/ZUA:_!&>8S#4L-.49QG?#5 MJ5.BG*M&7+"%.K54:<_VZ_X(6R:?+_P2I_9.;3%VVXTOXKQRC;L_XF$7QX^* M46K-C_;U5+UPW1P=XX85^M5?PG_\$9/^"V'A3]BSP-<_LQ?M.Z5XLU7X)?\` M"0WOB#X:?$'PI;/XAU?X67OB;4[.?Q-X:USPO/J%J]Y\-;J^GUCQS%>^$XKO MQ5HOB>^\11+X:\80^+K:7P?^TO[2?_!QS^P?\-/`U[=_L_ZOXL_:/^(U]8:A M'X=T32_`WC3X?>$=*U>-(A8S>.O$'Q*T3P=JMMH\K222`>#]"\6:A.UJUI/# MI27*:C%_)OC#]'?Q@Q'C'QC#*.!\]SO`<4\7YYG>39UEV$J8C):F"SS-,1F5 M#Z_F^F`RNMAHXOZOBXYI7P;5>C5E352C*E5J?MW`?BKP)1X!R*6/XAR[+L3D MF1Y=EV/R[$UE3S!5\NPE+!S^JX!)XG&PK.BJM%X*EB%[.I&,W&I&I"/\\GQC MN_">K?\`!P_I$_@&+=H\7_!2CX%6M\D$>W_BK-&^,'P]L/B2[*A;E?'5CXIE MN9#]XB65P"S*./\`#/\`RL#7'_:5KQ9_ZT_K->X?\$(_@=\3?VP?^"E&I_M8 M_$'RO$VC_"'6_&?QR^+GBS5M,LHK?Q+\7_BG%XKM_"-I:VFE?V;::;XBO?&. MLZS\3;1[#2QHFGV_@2^LC!8/?:/#+\K^)OB1X+^#W_!<3Q_\5OB-K7_".>`? MAU_P4R^(_C/QEKQT[5M7_L?PWX>_:1\0:GK&H_V7H5CJFM:@;2RMYIOL>E:= M?7]QL\NUM9I65#_>U)TJ7$?$WAOE]66<9SP1]&K+^'\Q^IRJ8RO5S?%4\51P M^!]G&E#$5<;7PV&P6-A'V*J5Z69X5QIQJ3=-?S0U.64Y+Q3B81P&7\0>+.*S M/">VC'#TZ>"H2PTZV(YUW M3?A;?^/O%.FH&:.%O#LM[<13VMI/"_+_`/#^K_@D]_T=9_Y@S]I+_P"<]7XC M_P#!Q#^W/\*?VDOV=OV*M#_9^\?Z-X]^%7Q3\3?%/XVW-[_87B'P]X@9_AA? MWOP6\(:J=%\7:/H'B;2-&OM>U;XVZ(O]HZ39IJU[X6:ZM!<6=M;W,O\`G;X+ M>"?'N(\7O#?"\6<"<7\/Y-4XIPN,Q&+XAX9SK)\NQ$+*N1\2Y%F>81R>MAZ5#*\XR M_'8NE_:5:AE$<5&CA,7*M&.'JYA2J.K;EIRY')2TA+<_X-N_BA^RC^SS\)?V ME/B5\:_VG_@)\)?'?Q*^(WA'P-8>!OBK\5_AO\/?$,'A/X9>&;C7[;Q7I=GX MMU_2-9N]&\4ZQ\4]3T>2ZMX7TN2]\#-%'+)=VERD'YV?LI^,_`O[*'_!=_PL M_P`(KKP1XT^#>O\`[6'BGX8?#L?"'XDZ+XG^'LWPJ_:3O=7\#?#=M.\8^';S MQ1HVN6'P^T;XE>%=:U;07O;J[AU[P?<^&-3N])UZQN+K3_6O@=_P;B?M,_'3 MX+?"+XVZ%\>/@3HNA_&'X9>!/BCHFD:JGCZ35-,T;Q_X7TOQ7I=CJ;V/A6>R M.H6MAJUO#>BTGN+9;E)5@GGB"RO^?/\`P43_`.":/QG_`.";7BKX8Z)\4/%/ M@_QGI_Q4T+7]8\+>*_`CZY'IHU'PGJ%A:>(M#F37--TJ^BU+28-<\-:B\T,; MP-!KMJ(I1-#,J_WSD5'P@XN\3?%W`Y9XLPX@XA\8,@S+A3-^$)X+$4*6#63Y M/4RR+P=2G#`_6:V395A\="WMHXF5)UZU+$TYJK4G_,>95^-LEX1X&K8K@:OE M67E>' MKG2_B=\-[6T\%:5>7GCW7FLKSX;:%:ZHNBR_$/5_M/[_`/L$UC_@L7^P[\+? M`'[/7B']HSXK?\*9\:_M`?LZ_"O]HW2/`W_""?%CX@G3/"OQ0TJXGM8)/$/P M]^'_`(DT22;3=(?"'Q<\6_&+Q#9I&FF^`?!/PC^*&A:]K$T\BP@QZK\3_"7@'PC96=KO%S MJ$]YXACNDLXYFTZPU2]$-A/_`!_X*<5_28\-J$>',E\,N*.-.!L?C\3AZN09 MMPIG&,X>G*OBIX7,GE7$5+"/`X&AB*T*T,16EB<7D7M98C%5\)4G4K59_O/B M%DOA#Q;4>;YAQ?D_#_$6'PU&M#,\%G.!H9JE"C&KA%C$8P@OEO_@AI_P6'\=?M<:UJ?[*7[4NJ:?K'QQT?0-8\7_#3XJX M\+^&G^*OAW2;NW?6_!.N^'K%M%M[OXD>%=.OFUO1KKP;HZ%XDU7Q/ M8:1K/@C4_$WCS^/?]F/X2_M%_&_X\:'\./V4[3Q!>_&[64\4W'A>W\+^.-'^ M'.M/9Z3HFJ:IXC-MXMUWQ)X2TS3T3P_::DUQ%/KMJU];B2RA2YFG2WE_2[_@ MWQ^'/BKX@?\`!47X5^,_#]A8C1/@_P"$/C%\1_&[&86L6F^'==^'7B3X4:>F ME12>8;JZ;Q?\3O#%O%8++YPTK^T;X,\>GS9\$_X)#?M#?![]EG_@H+\,?C7\ M>/&'_""?#+PQI?Q5L];\2_V!XH\3_8KGQ#\//%6@:/$-&\&Z)XAU^Y^UZMJ- MG:[[32IX[?S?/N7AMXY)4_M/+.&,J\+^*_I(U?##A_!8G'U?#?@GBS#\&X7` M5\?ERXIJ4_$^-+(Z&2Y=4IXB6&S-X#`8I91@94&XYDZ&`A0H3P\(?SSF&<8[ MC')?"2'%^95X8:'%V?Y%6SRO7AA\3_8:K\$>VS*KF&+C*E[;`PQ>+A_:&(52 M,7@U4Q3JU*=:4OTM_9,_X)P?\%NO!'[5'[-'C7XL:!\9K;X6>#_V@/@WXJ^) M4^K?M9_#;Q-I<7@#P]\1/#FK^,6U'PYIOQRUF_UZR_X1VSU$7.C6>DZG80O\`W#U^0/\`P_J_X)/?]'6?^8,_:2_^<]7ZG?#SQ[X3^*O@#P/\ M4/`6J_V[X%^)'@_PUX]\%ZY]AU+2_P"V?"?C#1;+Q#X^L[6ZCE@3_-[QYXE\5>,L7D.=>)'ADO#V.#P^)RO+ M987@OB/A/`YC*I46+K*3SZOBEB\725FEAZL.2B[RIN_,?UMX:9-P3P]0S/+^ M$>+8\3/$5:.,QD:F?93G6(PJC#V%-I992HNC1GM^]A)2FK1DM4=A7Q?^W5^P MI\'O^"A'P>T7X*?&O6OB#H'ACP_\0-(^)6EZG\--9T'0_$4'B/1?#_BKPS:A M[GQ)X7\7Z5-I\FE^,-86XM9='=WG-K+'/%Y)63[0HK\1R3.\VX;S;`9[D6/Q M&69OEF(CBL!C\+)0Q&%Q$$U&K2DU)*24FM4TTVFFF?HF8Y=@PKW_P#9[_X-\O\`@G/\!?%7_"8:IX4\?_M!:E:W-G>:+I_[ M0?B;0/%7A719[5;A)<^#/!WA#P#X3\4VM^MP!>Z=\0-&\8:8&@MY;2SM)D:1 M_P!B?B3>>(-.^'?CS4/":W3^*;'P;XHO/#:6-BFJ7SZ];:'?3Z0MGIDD%S'J M-V=02W^SV#V]PEW-LMV@E$GEM\N^)/%/A8ZOH?A;PG?:/XCT74=9^$.NZ9XF MTWXQ>(?B#?W-MH/[0'P5L9QXBT#5%O;.PN[V_P#%%RFF:^OB+6K_`%"TT>YB MN)+9?]$M7XF?32\7>&<-F.5YQXB<2U\//(WC:E&>=XW*J^:SQ7]IPP65Y95R M;)\=B9*KB,JEA,Q6+AA<+ED\7E<_:U:V+IP MIY'[>W_!/7X+_P#!1+X?^"OAQ\:_$WQ/\+:'X$\8R>-M(N_A;K7A31-5N-5D MT74-":WU*?Q9X*\;6@V/E:;#9PW'VJZCFO+CRGQ3\4M:UOPGX2FU7Q+X75=57X5^ M.O&,'?$FS5X)[2R@_M+Q';ZC:>);K3]8?5/`WB MB2._L;>.XTKP_O>-/CSK'A;1/%KVVMV>J2>&5\=WGA7Q+##X2CT7QK!X1\/> M![ZTAU6ZU#Q-I,5]&GBKQ==^!->LOA]IUYK.HZWH]PM@_A*^B.D7?XEF'TO, MOAPI6X2S3,L_7`'#F%R3C/!9:JF58FG#,^(%Q%RU:>6X?&SKTYT\OI5ZT\P^ MLUL%2Q./Q.28Z>7YYAXY?B-GXA<`8#.$],\6WT]C9V1FU'P=XJ\+>.?`N MBRN;,ZE?77@OPQX6OM7^%O$7Q%^'%MH/B&V@D5Y=)UBX\)_!WPOXGAT^]4&&YDT# MQ'H>JI&S&SU.TEVRK^Q5]K`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`8:>)S*I5P>&_*K_ M`(A@/V!?^BN_M?\`_A??!C_YP%>B>-O^#<[]B;Q[X;^$/A;6OBM^U5%IWP4^ M'6H_#'PE)I_C;X007=UX>U7XL?$_XR7$^N2S_`RZBO-47Q5\6O$UM#<6<.G6 MRZ+;Z/:-9O>6MUJ%]^J&M_$[Q3I'AR\\8ZKXETJRT>'Q/\3;"YT:P_X1BQ\1 M0:)\//%_B/P_:WOAZW\6:C96/B-Y(M/MKSQG;3:E8WBZ?Y%OX6C@U9O^)KPF MO^(_$_A'X5>,;R#4;.[TGQ'XU_:VT1-%-C=6+V":7)\?O&]KJ$>M:?JMMJ[: MH^K^$9[2>>VN+&W&CZC;16-K8:OIDFM:E]KF_P"T#\3Z->-1\7<>8I91D%+B M^.(KXC)Z$\'1S=95E>08N-*G/$U7A;8R4HTJ+^HXS&9*\G.T ML--TZPLXX;2QL+&UABM;.SM88K>VMXHX(8TC15'Y^_\`!0#_`()E?L]_\%'] M.^%]C\K_"SQ#X:T+4C#XW@\.P^(M.U1?%?@WQMIEW M97K>&O#?@MO'MQHFO7WE:I<:DFH^;X=\.V.HWUW;0:+!+OX?0Z#8W M*3WB[-)NQX@OHM<@LFL[RYM]BZ7?:/=G[:/D.&?I"4N'9X;Q`X3Q?$&!S/+< MTEE^%QV75,LEFU/&9GE64U).C*.95L(GB.XJX2XAX9 M9=/V=7$X>MA:U.I3JTZ=:@Z;_*+XA?\`!NY^QA\3?#OP9\,^)OB[^UA):_`W MX7W'PC\(7EOX^^%+:E>^%)OBC\3?BQ;G7KC4/@E?QW-]INL_%36]"TS^S(-( MTVS\*:3XI:CY>?^#7_`/8&PX\??!?(]QG]G\C/U!K] MTO$_C;2?#/Q)^'-QXE\4:=X8T+5OAS\3)I5UK7;?1]'O-8AU[X0/IH?[==6U ME=:E:V5WK(L"P>ZAM;C4_(V1370;S[4?C3JFH^(/$>G^%=:TC3[6PB\46DTO MC*Y\*Z=IUE>^#_B/X-\"71TF^L==O;W3;O7CJGBFR\._\)Y86MMKOB*#PW<: M?96^B0:M'JGZCC_IR^(7"M3.LKJ>)W$\,1E.<3H3RO+,3EN)S"M+,\HRGBJM MF7U&2H5<-A\3B.)*6'4JKBIXVK[EJ=1^S^6S?*O!W!8G,:68<+Y;7QN6XC"X M&6%P\8XC'5*$,DRK&X?$/#2Q=*=+#QH8_"X*G*JUSU8QLW&3<:'['W["_P"S M/^PKX'U/P/\`LY_#^/PLGB671[SQQXLU34+SQ#XZ\?:KH>F_V;I^H^*O$VIR M27,L5JLNHWNG>'-'BT?P9H&I:[XCO?#7AK19/$&K_;/R!E_X-@_V!Y99)6^+ MG[7P:61Y&"^/O@QM!=BQ`S\`2<`GC))QU)K]@-/^-NNZOKF@Z=I%_$UI/8Z% M+:-K[^`M+N/$&H-\3O%W@/QEI6IW*>,(K+4KK1;7P[9VVEW?PT_M6TE\2ZII MVJW,%WH6JZ1X?U"]J_Q+\7^&?#/A;QIXG\7:';:1J^AZOXAUG3].M_#UKKEE M;:7)I+:?=Z+HWB+4K6?Q'X>M=.O+J7X@V>F:E+XMGU2XT&W\#V]J;Y].E^*X M?^FOQ!DE3B7B_A_B[Q`I5,[P^"S;BKB/FP-5X_"Y?B,)EV#QF.S',\SD\31P M,\^A3IRHU*BH8&I/$Q2RV-"M*L;F?A7G64X)8KA1XO).'\)6KX)K`8/#9?EF M"QF*RZABJU&V/P]+V57$5\'4Q$Z?M'*$98V5Z$E7J?C;_P`0P'[`O_17?VO_ M`/POO@Q_\X"OT7TG_@F?X,T#P[X-\)^'OVK/V\/#7AWP)X"\`?#GP[HOA3]J M#Q1X0T2T\/\`PX\%Z#X%T-XO#WA+3M#\.6-]>:5X>M+[6GTC1]-M+_6KG4-1 M6S@>[=!^DHZ#Z"EK]RSGQP\6.(EAXYYQQG.:1PCJRPRQCPM54765-5733P^C MJ*E34GUY5YW^]P?AMP-E_M/J/#>`PGMN3VOU=XBDZGL^;DYG"LF^7GE9/1.3 M84445^5'W`AZ'Z'^50JB*LO_4F!F_BCZU/_3],#P3CCD]*1E4J&(!9-Q1B M`2AP%RIZJ<,PR,'#$=":**WJ_"O^OE'_`-.P-*GPK_'3_P#3D09$V%-B[7W; MUVC:WF`,^X8PV]F9GR#N+$G))I"JL`656*.K(2`2K`,`RY^ZP!(!&#@FBBN> M7P?]P:'_`*69_9_[>I^I_ MG116\?XM7TI_E(N/\2I_VY_Z2>7_``?`_P"$8U=L#N`22!T!)/4FO4/XR.V'HHKY#P]_Y(+@G_LE^'O_`%4X0\#@_P#Y)3AK_L09 M-_ZK<,.7H_T_QIAC0A@40B4'S`5&)/W2K\XQ\_R@+\V>`!T%%%?75_A7_;__ M`*9J'O3^"/H__3A(HV*Y0NJL4D5D L+`,4;!&Y<@[6QQD8..***S?P/_KY2_\`2*1*_AOUI_\`I-,L4445U&Y__]D_ ` end